Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Achillion Pharmaceuticals, Inc. (NQ: ACHN)
7.750 USD  +0.200 (+2.65%)
Official Closing Price  /  Updated: 5:20 PM EDT, May 21, 2013  /  Add to My Watchlist      
View: Quote News Research
Stories about Achillion Pharmaceuticals, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9 Next >
7 Biotechnology Stocks to Sell Now
May 15, 2013
 Read More
category NASDAQ:TSRX , NASDAQ:ACHN , NASDAQ:EXEL , and 5 more.
from InvestorPlace - Latest Headlines
7 Biotechnology Stocks to Sell Now
May 08, 2013
 Read More
category NASDAQ:TSRX , NASDAQ:ACHN , NASDAQ:EXEL , and 5 more.
from InvestorPlace - Latest Headlines
Achillion Pharmaceuticals, Inc. (ACHN) Posts Q1 Loss of 14c/Share
May 07, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8310329 for the full story. Read More
from StreetInsider.com News Articles
Oversold Conditions For Achillion Pharmaceuticals Inc. (ACHN)
May 02, 2013
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a... Read More
category Stocks
from Market News Video
7 Biotechnology Stocks to Sell Now
May 01, 2013
 Read More
category NASDAQ:TSRX , NASDAQ:ACHN , NASDAQ:EXEL , and 5 more.
from InvestorPlace - Latest Headlines
7 Biotechnology Stocks to Sell Now
April 24, 2013
 Read More
category NASDAQ:TSRX , NASDAQ:ACHN , NASDAQ:EXEL , and 5 more.
from InvestorPlace - Latest Headlines
8 Biotechnology Stocks to Sell Now
April 17, 2013
 Read More
category NASDAQ:TSRX , NASDAQ:ACHN , NASDAQ:EXEL , and 6 more.
from InvestorPlace - Latest Headlines
Achillion (ACHN) Commences ACH-3102 Phase 2
April 16, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8254639 for the full story. Read More
from StreetInsider.com News Articles
7 Biotechnology Stocks to Sell Now
April 10, 2013
 Read More
category NASDAQ:TSRX , NASDAQ:ACHN , NASDAQ:EXEL , and 5 more.
from InvestorPlace - Latest Headlines
7 Biotechnology Stocks to Sell Now
April 03, 2013
 Read More
category NASDAQ:TSRX , NASDAQ:ACHN , NASDAQ:EXEL , and 5 more.
from InvestorPlace - Latest Headlines
7 Biotechnology Stocks to Sell Now
March 27, 2013
 Read More
category NASDAQ:TSRX , NASDAQ:ACHN , NASDAQ:EXEL , and 5 more.
from InvestorPlace - Latest Headlines
7 Biotechnology Stocks to Sell Now
March 20, 2013
 Read More
category NASDAQ:TSRX , NASDAQ:ACHN , NASDAQ:EXEL , and 5 more.
from InvestorPlace - Latest Headlines
8 Biotechnology Stocks to Sell Now
March 13, 2013
 Read More
category NASDAQ:TSRX , NASDAQ:ACHN , NASDAQ:EXEL , and 6 more.
from InvestorPlace - Latest Headlines
7 Biotechnology Stocks to Sell Now
March 06, 2013
 Read More
category NASDAQ:TSRX , NASDAQ:ACHN , NASDAQ:EXEL , and 5 more.
from InvestorPlace - Latest Headlines
UPDATE: Piper Jaffray Cuts PT to $15 on Achillion Pharmaceuticals on Equity Offering Dilution
March 04, 2013
Piper Jaffray maintained Achillion Pharmaceuticals (NASDAQ: ACHN ) with an Overweight rating and lowered the price target from $16.00 to $15.00. Piper Jaffray said, "Achillion now holds proforma cash... Read More
category Benzinga , Piper Jaffray , ACHN , and 3 more.
from Latest Articles from Benzinga.com
7 Biotechnology Stocks to Sell Now
February 27, 2013
 Read More
category NASDAQ:TSRX , NASDAQ:ACHN , NASDAQ:EXEL , and 5 more.
from InvestorPlace - Latest Headlines
Snag ACHN Even Lower Than Its Secondary?
February 25, 2013
Looking back to 4 days ago, Achillion Pharmaceuticals Inc. (ACHN) priced a 15,000,000.00 share secondary stock offering at $8.40 per share. Read More
category Stocks
from Market News Video
Achillion Pharmaceuticals (ACHN) Prices 15M Shares at $8.40
February 22, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8123370 for the full story. Read More
from StreetInsider.com News Articles
Biotech and Bioheath Stocks Raising Capital, Secondary Offerings
February 22, 2013
DailyFinance.com : It is not unusual to see biotech and biohealth companies raise cash after good news. After all, these companies either need to raise lots of cash from the market to fund their... Read More
category neo , achn , etrm , and 1 more.
from DailyFinance.com
Achillion Pharmaceuticals Prices 15M Share Offering at $8.40/Share
February 21, 2013
Achillion Pharmaceuticals (NASDAQ: ACHN ) announced today the pricing of an underwritten public offering of 15,000,000 shares of its common stock at a price to the public of $8.40 per share. The net... Read More
category Contracts , Management , Benzinga , and 3 more.
from Latest Articles from Benzinga.com
Achillion Pharma (ACHN) Announces $125M Common Offering
February 20, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8116844 for the full story. Read More
from StreetInsider.com News Articles
6 Biotechnology Stocks to Sell Now
January 30, 2013
 Read More
category NASDAQ:RIGL , Stocks to Sell , NASDAQ:RPTP , and 4 more.
from InvestorPlace - Latest Headlines
8 Biotechnology Stocks to Sell Now
January 16, 2013
 Read More
category NASDAQ:FOLD , NYSE:ELN , NASDAQ:ACHN , and 6 more.
from InvestorPlace - Latest Headlines
Mid-Day Market Update: SolarCity Wins Big, SunPower Continues its Fall
January 07, 2013
Following the market opening Monday, the Dow traded down 0.59 percent to 13,355.80 while the NASDAQ fell 0.38 percent to 3,089.47. The S&P also fell, decreasing 0.61 percent to 1,457.25. Top Headline... Read More
category Earnings , Benzinga , Movers , and 23 more.
from Latest Articles from Benzinga.com
Morning Market Losers
January 07, 2013
ITT Educational Services (NYSE: ESI ) shares dipped 19.49% to $15.53 at 9:54 am. ITT Educational Services agreed to pay $46 million to Sallie Mae to settle loan dispute. Innsuites Hospitality Trust... Read More
category Morning Market Losers , Benzinga , News , and 9 more.
from Latest Articles from Benzinga.com
Achillion Pharma (ACHN) Completes Enrollment in ACH-3102 Phase 2a; No Adverse Effects Reported
January 07, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7988869 for the full story. Read More
from StreetInsider.com News Articles
Baird Starts Achillion Pharmaceuticals (ACHN) at Outperform
January 03, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7983255 for the full story. Read More
from StreetInsider.com News Articles
Bank of America Merrill Lynch Reiterates Buy Rating, $13 PT on Achillion Pharmaceuticals
December 26, 2012
In a report published Wednesday, Bank of America Merrill Lynch reiterated its Buy rating and $13.00 price target on Achillion Pharmaceuticals (NASDAQ: ACHN ). BofA Merrill Lynch noted, “In early... Read More
category Reiteration , US00448Q2012 , Benzinga , and 4 more.
from Latest Articles from Benzinga.com
Achillion Pharmaceuticals Inc. is Now Oversold (ACHN)
December 03, 2012
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a... Read More
category Stocks
from Market News Video
Lessons from the Liver Meeting: Sagient’s John Tucker Names Companies That Could Reignite the Hepatitis C Industry
November 30, 2012
category Pharmaceuticals
from Trefis
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here